Award

Determinants of Response of Acute Myelocytic Leukemia

Funder: National Institutes of Health

Funding type: cooperative_agreement

Funder scheme: U10

Start date: 1980-09-01

End date: 1990-04-30

Investigator: HARVEY D PREISLER

Institution: ROSWELL PARK CANCER INSTITUTE

Funded outputs count: 14

Funder award ID: 2u10ca028734-05

OpenAlex ID: G7991892881

Structural Characterization of Heparan Sulfate and Chondroitin Sulfate of Syndecan-1 Purified from Normal Murine Mammary Gland Epithelial Cells

2001 · Momoyo Ueno, Shuhei Yamada, et al. · Journal of Biological Chemistry · 75

Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts: implications for their roles in cell-substratum adhesion

1993 · Masahito Yamagata, Shinsuke Saga, et al. · Journal of Cell Science · 142

Clinical and prognostic significance of in vivo differentiation in acute myeloid leukemia

1993 · Azra Raza, Harvey Preisler, et al. · American Journal of Hematology · 17

Long Term Outcome of Patients with Acute Myelogenous Leukemia: The Role of Maintenance Therapy, Consolidation Therapy and the Predictive Value of Twoin vitroAssays

1993 · A. Raza, H. D. Preisler, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 3

Relationship of [3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study.

1992 · A Raza, S Gezer, et al. · PubMed · 28

The selective use of AMSA following high‐dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup Study

1992 · Richard A. Larson, Roger S. Day, et al. · British Journal of Haematology · 16

High expression of transforming growth factor-beta long cell cycle times and a unique clustering of S-phase cells in patients with acute promyelocytic leukemia [see comments]

1992 · A Raza, N Yousuf, et al. · Blood · 27

The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukaemia: response to treatment and treatment failure

1991 · Harvey D. Preisler, Richard A. Larson, et al. · British Journal of Haematology · 22

Biological significance of cell cycle kinetics in 128 standard risk newly diagnosed patients with acute myelocytic leukaemia

1991 · Azra Raza, Harvey Preisler, et al. · British Journal of Haematology · 21

Circulating immune complexes correlate with remission duration in acute myeloid leukemia.

1991 · R A Larson, C L Lukin, et al. · PubMed · 3

Cell cycle and clinical characteristics of patients with acute myeloid leukemia and myelodysplasia whose biopsies are reactive with anti-factor VIII antibody

1991 · Shakila P. Khan, Azra Raza, et al. · Leukemia Research · 4

Detection of single-stranded DNA damage using monoclonal anti-thymidine antibody

1991 · Azra Raza, Iqbal Mehdi, et al. · Leukemia Research

Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics: a leukemia intergroup study

1990 · A Raza, HD Preisler, et al. · Blood · 98

Continuous infusion mitoxantrone in relapsed acute nonlymphocytic leukemia

1990 · Lynne S. Kaminer, Kyung E. Choi, et al. · Cancer · 10